Consolidated Balance Sheet

Kringle Pharma,Inc. - Filing #7357145

Concept As at
2023-12-31
As at
2023-09-30
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Property, plant and equipment
Property, plant and equipment
JPY
JPY
Investments and other assets
Investments and other assets
1,122,000 JPY
1,040,000 JPY
Non-current assets
1,122,000 JPY
1,040,000 JPY
Current assets
Cash and deposits
2,341,394,000 JPY
2,136,490,000 JPY
Accounts receivable - trade
24,994,000 JPY
7,560,000 JPY
Raw materials and supplies
364,056,000 JPY
364,056,000 JPY
Advance payments to suppliers
12,966,000 JPY
21,065,000 JPY
Other
12,540,000 JPY
14,154,000 JPY
Current assets
2,843,577,000 JPY
2,617,617,000 JPY
Assets
2,844,699,000 JPY
2,618,657,000 JPY
Liabilities
Non-current liabilities
Non-current liabilities
389,466,000 JPY
387,900,000 JPY
Asset retirement obligations
2,305,000 JPY
2,305,000 JPY
Current liabilities
Accounts payable - other
54,253,000 JPY
171,662,000 JPY
Income taxes payable
372,000 JPY
1,490,000 JPY
Other
13,123,000 JPY
9,901,000 JPY
Advances received
26,000,000 JPY
26,000,000 JPY
Current liabilities
93,750,000 JPY
209,054,000 JPY
Liabilities
483,216,000 JPY
596,955,000 JPY
Liabilities and net assets
Shareholders' equity
2,351,618,000 JPY
2,007,006,000 JPY
Share capital
354,595,000 JPY
97,546,000 JPY
Capital surplus
3,352,566,000 JPY
3,095,517,000 JPY
Retained earnings
-1,355,467,000 JPY
-1,185,981,000 JPY
Treasury shares
-75,000 JPY
-75,000 JPY
Share acquisition rights
9,865,000 JPY
14,696,000 JPY
Net assets
2,361,483,000 JPY
2,021,702,000 JPY
Liabilities and net assets
2,844,699,000 JPY
2,618,657,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.